A Ph 1 Study of Epanova® in Healthy Chineses

Clinical trial NCT03574142 · COMPLETED

Trial details

NCT number: NCT03574142
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2018-06-04
Primary completion: 2018-06-27
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.